Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for LifeMD (LFMDP) over the last 9 years, with Q3 2025 value amounting to $262747.0.

  • LifeMD's Depreciation and Depletion rose 7362.29% to $262747.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $775847.0, marking a year-over-year increase of 10451.26%. This contributed to the annual value of $487976.0 for FY2024, which is 13926.02% up from last year.
  • Latest data reveals that LifeMD reported Depreciation and Depletion of $262747.0 as of Q3 2025, which was up 7362.29% from $184256.0 recorded in Q2 2025.
  • In the past 5 years, LifeMD's Depreciation and Depletion ranged from a high of $262747.0 in Q3 2025 and a low of $10695.0 during Q4 2021
  • Over the past 5 years, LifeMD's median Depreciation and Depletion value was $53759.0 (recorded in 2023), while the average stood at $92129.8.
  • In the last 5 years, LifeMD's Depreciation and Depletion surged by 31960.73% in 2022 and then soared by 1391.88% in 2023.
  • Quarter analysis of 5 years shows LifeMD's Depreciation and Depletion stood at $10695.0 in 2021, then skyrocketed by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then soared by 188.35% to $166278.0 in 2024, then soared by 58.02% to $262747.0 in 2025.
  • Its last three reported values are $262747.0 in Q3 2025, $184256.0 for Q2 2025, and $162566.0 during Q1 2025.